Rezultati - Agustin Pimentel
- Showing 1 - 3 results of 3
-
1
-
2
Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United States od Luis Malpica, Agustin Pimentel, Isildinha M. Reis, Eduardo Gotuzzo, Lazaros J. Lekakis, Krishna V. Komanduri, Thomas J. Harrington, Glen N. Barber, Juan Carlos Ramos
Izdano 2018Artigo -
3
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial od Andrea J. Bullock, Benjamin L. Schlechter, Marwan Fakih, Apostolia M. Tsimberidou, Joseph E. Grossman, Michael S. Gordon, Breelyn A. Wilky, Agustin Pimentel, Daruka Mahadevan, Ani Sarkis Balmanoukian, Rachel E. Sanborn, Gary K. Schwartz, Ghassan K. Abou‐Alfa, Neil H Segal, Bruno Bockorny, Justin C. Moser, Sunil Sharma, Jaymin Patel, Wei Wu, Dhan Chand, Katherine Rosenthal, Gabriel Mednick, Chloé Delépine, Tyler J. Curiel, Justin Stebbing, Heinz‐Josef Lenz, Steven O’Day, Anthony B. El-Khoueiry
Izdano 2024Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Cancer
Chemotherapy
Clinical trial
Colorectal cancer
Gastroenterology
Oncology
Acute leukemia
Adverse effect
Astrobiology
Bevacizumab
Biology
Capecitabine
Chronic leukemia
Clinical endpoint
Cohort
Discontinuation
Disease
Environmental health
Epidemiology
Immunology
Intensive care medicine
Irinotecan
Leukemia
Lymphoma
Oxaliplatin
Pathology
Phases of clinical research
Population